| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 18 |
| 1 | METHOTREXATE | 14 |
| 2 | EVEROLIMUS | 12 |
| 3 | LOPERAMIDE HYDROCHLORIDE | 12 |
| 4 | ONDANSETRON HYDROCHLORIDE | 12 |
| 5 | AMLODIPINE BESYLATE | 11 |
| 6 | LOPERAMIDE HCL | 11 |
| 7 | LOPERAMIDE HYDROCHLORIDE ORAL | 11 |
| 8 | ONDANSETRON | 10 |
| 9 | ONDANSETRON TABLETS | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POTASSIUM NITRATE AND SODIUM FLUORIDE | 1 | 0.0017 |
| 1 | LANREOTIDE ACETATE | 9 | 0.0011 |
| 2 | EPINASTINE HYDROCHLORIDE | 1 | 0.0009 |
| 3 | LOPERAMIDE HCL | 11 | 0.0008 |
| 4 | SENNOSIDES A AND B | 1 | 0.0006 |
| 5 | DOPAMINE HYDROCHLORIDE | 2 | 0.0005 |
| 6 | BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | 3 | 0.0005 |
| 7 | MAGNESIUM CITRATE ORAL SOLUTION | 3 | 0.0005 |
| 8 | MAGNESIUM CITRATE | 3 | 0.0005 |
| 9 | CLINDAMYCIN PHOSPHATE TOPICAL | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 24 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 14 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12 |
| 3 | Serotonin-3 Receptor Antagonist [EPC] | 12 |
| 4 | mTOR Inhibitor Immunosuppressant [EPC] | 12 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 10 |
| 6 | Corticosteroid [EPC] | 8 |
| 7 | Factor Xa Inhibitor [EPC] | 7 |
| 8 | Vitamin C [EPC] | 7 |
| 9 | Benzodiazepine [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 1 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 2 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | Serotonin-3 Receptor Antagonist [EPC] | 12 | 0.0001 |
| 4 | Alkaloid [EPC] | 2 | 0.0001 |
| 5 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 6 | Epidermal Growth Factor Receptor Antagonist [EPC] | 3 | 0.0001 |
| 7 | Nitrofuran Antibacterial [EPC] | 1 | 0.0001 |
| 8 | Interleukin-17A Antagonist [EPC] | 2 | 0.0001 |
| 9 | Kinase Inhibitor [EPC] | 24 | 0.0000 |